drugset / Trial / NCT00538616
Precedex Versus Propofol-Awakening for Reducing Brain Injury Expansion
Phase 1/2
Completed
8 enrolled
Carmelo Graffagnino
Hospira, now a wholly owned subsidiary of Pfizer · collab
RandomizedCrossoverSingle-blindTreatment
Summary
The purpose of this study is to evaluate brain injury when two different drugs (propofol and precedex) are used to sedate patients who need a neurologic exam.
Timeline
- Start
- 2008-01
- Primary completion
- 2008-02
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | — | — |
| Comparator | Propofol | Small molecule | — | — |